Emerging Therapies in Lower Respiratory Tract Infection Management
Received Date: Oct 03, 2023 / Published Date: Oct 30, 2023
Abstract
Lower respiratory tract infections (LRTIs) pose a significant global health burden, necessitating innovative approaches to management. This article explores the landscape of emerging therapies in LRTI management, highlighting the potential of phage therapy, monoclonal antibodies, host-directed therapies, nanotechnology, immunomodulatory agents, CRISPR-Cas9 technology, mRNA vaccines, and microbiome-based interventions. These promising therapies offer new avenues to combat drug-resistant pathogens, enhance the immune response, and revolutionize the treatment of LRTIs, ultimately improving patient outcomes.
Citation: Woodhead P (2023) Emerging Therapies in Lower Respiratory Tract Infection Management. J Infect Pathol, 6: 209. Doi: 10.4172/jidp.1000209
Copyright: © 2023 Woodhead P. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.